Page last updated: 2024-10-24

bupivacaine and Crush Syndrome

bupivacaine has been researched along with Crush Syndrome in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Crush Syndrome: Severe systemic manifestation of trauma and ischemia involving soft tissues, principally skeletal muscle, due to prolonged severe crushing. It leads to increased permeability of the cell membrane and to the release of potassium, enzymes, and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurita, S1
Oda, Y1
Terai, T1
Yukioka, H1
Fujimori, M1
Asada, A1

Other Studies

1 other study available for bupivacaine and Crush Syndrome

ArticleYear
[Two cases of crush syndrome associated with intractable pain].
    Masui. The Japanese journal of anesthesiology, 1997, Volume: 46, Issue:4

    Topics: Adult; Analgesia, Epidural; Anesthetics, Local; Bupivacaine; Crush Syndrome; Fasciotomy; Female; Hum

1997